Power Law company profile

TransMedics

Biotech & Life Sciences · Andover, United States · Founded 1998 · IPO 2019 Unicorn

The world’s leader in portable ex-vivo perfusion and assessment of donor organs for transplantation

Valuation

$3.51B

Market cap · May/2026

Revenue

$605M

Latest reported FY

EBITDA

$165M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

16 investors on TransMedics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 16 investors entered at this stage

POSCO BioVentures

Millhouse

Abrams Capital

Alta Partners

BioStar Capital

Pharmstandard

Novel Bioventures

VantagePoint Capital Partners

OrbiMed

Inbio Ventures

Lung Biotechnology

POSCO BioVentures

Flagship Pioneering

3i Group

Sherbrooke Capital

Kleiner Perkins

Global footprint

Where TransMedics has talent and traffic

AI talent share

0.2% of workforce is AI talent
(1 of 666 staff)

Core AI00%

Other AI10.15%

Non-AI workforce66599.85%

Workforce by country

12 countries with
team presence

🇺🇸 United States95.7%

🇮🇹 Italy1.5%

🇩🇪 Germany0.8%

🇮🇳 India0.5%

🇧🇭 Bahrain0.3%

Top 5 of 12 shown

Web traffic by country

26K monthly visits
across markets

🇺🇸 United States45.4%

🇮🇳 India11.5%

🇨🇦 Canada10.8%

🏳️ Korea8.1%

🏳️ Republic of7.3%

Top 5 markets shown

Patent intelligence

$129M patent portfolio · 30 active families

Estimated portfolio value

$129M

3.7% of market cap · 3.9× smaller than top peer Insulet ($502M)

30 active patent families

Where TransMedics innovates Perfusion fluidBiomedical engineeringBreathingEx vivoGas exchange

Where TransMedics concentrates vs peers

Each axis is a top-10 topic across TransMedics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about TransMedics

An AI-synthesized read of the highest-engagement posts about TransMedics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See TransMedics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles